神经类固醇:神经精神疾病的潜在目标
Mengyu Wang1, Suwan Hu1, Xinghuo Fu1
1Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
The Journal of steroid biochemistry and molecular biology
|February 18, 2024
概括
神经类固醇在大脑和身体中产生,调节神经功能. 异常与阿尔茨海默氏症等疾病有关,这表明神经类固醇疗法对大脑健康有希望.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经类固醇在大脑和内分泌腺体中合成.
- 它们在神经元信号传递,突触可塑性和神经保护中起着至关重要的作用.
- 神经类固醇的失调与神经精神疾病 (如阿尔茨海默病,精神分裂症和) 有关.
研究的目的:
- 审查神经类固醇在大脑中的生理作用.
- 探索神经类固醇功能障碍与主要神经精神疾病之间的联系.
- 讨论针对神经类固醇及其类型的治疗潜力.
主要方法:
- 关于神经类固醇合成,功能和疾病相关性的文献综述.
- 在临床前模型中对神经类固醇类似物进行当前研究的分析.
- 综合发现,突出治疗意义.
主要成果:
- 神经类固醇是大脑功能的重要调节剂.
- 证据强烈地将神经类固醇失衡与阿尔茨海默病,精神分裂症和的病理生理学联系起来.
- 合成神经类固醇类似物显示出治疗这些疾病的潜力.
结论:
- 神经类固醇对于维持大脑健康和功能至关重要.
- 准神经类固醇通路为神经精神疾病提供了一个有前途的治疗途径.
- 对合成类型的进一步研究可能会导致新的治疗方法.
更多相关视频
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Neurochemical Transmission: Sites of Drug Action
2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K
Neurotransmitters
948
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
948
Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K


